Viewing Study NCT03091933

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-01-11 @ 11:23 AM
Study NCT ID: NCT03091933
Status: UNKNOWN
Last Update Posted: 2017-12-06
First Post: 2017-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
Sponsor: Ciusss de L'Est de l'Île de Montréal
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Cancer View
None Relapse Leukemia View
None Relapsed Adult ALL View
None Relapsed Adult AML View
None Relapsed CLL View
None Relapsed Non Hodgkin Lymphoma View
None Relapsed Hodgkin's Lymphoma View
None Relapsed Myelodysplastic Syndromes View
None Relapsed Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None allogeneic hematopoietic stem cell transplantation View
None relapsed hematopoietic malignancy View
None HLA matched donor View
None minor histocompatibilty antigen (MiHA) View